Systematic review of patients’ and healthcare professionals’ views on patient‐initiated follow‐up in treated cancer patients
Cancer Medicine · 2023-08 · 12 (15) · 16531-16547
DOI: 10.1002/cam4.6243 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Cancer Medicine, online erschienen am 16.06.2023. Verfasst von Janine Dretzke und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Applied Health Research, University of Birmingham, Birmingham, UK. Hauptthemen laut MEDLINE: Health Personnel. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancer Research UK, National Institute for Health Research (NIHR) Programme, National Institute for Health and Care Research.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background
Current follow‐up models in cancer are seen to be unsustainable and inflexible, and there is growing interest in alternative models, such as patient‐initiated follow‐up (PIFU). It is therefore important to understand whether PIFU is acceptable to patients and healthcare professionals (HCPs).
Methods
Standard systematic review methodology aimed at limiting bias was used for study identification (to January 2022), selection and data extraction. Thematic synthesis was undertaken for qualitative data, and survey findings were tabulated and described.
Results
Nine qualitative studies and 22 surveys were included, mainly in breast and endometrial cancer. Women treated for breast or endometrial cancer and HCPs were mostly supportive of PIFU. Facilitators for PIFU included convenience, control over own health and avoidance of anxiety‐inducing clinic appointments. Barriers included loss of reassurance from scheduled visits and lack of confidence in self‐management. HCPs were supportive of PIFU but concerned about resistance to change, unsuitability of PIFU for some patients and costs.
Conclusion
PIFU is viewed mostly positively by women treated for breast or endometrial cancer, and by HCPs, but further evidence is needed from a wider range of cancers, men, and more representative samples. A protocol was registered with PROSPERO (CRD42020181412).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Applied Health Research, University of Birmingham, Birmingham, UK.
- Bristol Medical School: Population Health Sciences, University of Bristol, Bristol, UK.
- Institute of Head and Neck Studies and Education, University of Birmingham, Birmingham, UK.
ORCID-Profile: Janine Dretzke, Paul Nankivell
Förderung
- Cancer Research UK
- National Institute for Health Research (NIHR) Programme
- National Institute for Health and Care Research
Zitieren
APA
Dretzke, J., Lorenc, A., Adriano, A., Herd, C., Mehanna, H., Nankivell, P., Moore, D. J., & PETNECK2 Research Team (2023). Systematic review of patients’ and healthcare professionals’ views on patient‐initiated follow‐up in treated cancer patients. Cancer Medicine, 12(15), 16531-16547. https://doi.org/10.1002/cam4.6243
Vancouver
Dretzke J, Lorenc A, Adriano A, Herd C, Mehanna H, Nankivell P, et al. Systematic review of patients’ and healthcare professionals’ views on patient‐initiated follow‐up in treated cancer patients. Cancer Medicine. 2023;12(15):16531-16547. doi:10.1002/cam4.6243
BibTeX
@article{Dretzke2023,
author = {Dretzke, Janine and Lorenc, Ava and Adriano, Ada and Herd, Clare and Mehanna, Hisham and Nankivell, Paul and Moore, David J and PETNECK2 Research Team, PETNECK2 Research Team},
title = {Systematic review of patients’ and healthcare professionals’ views on patient‐initiated follow‐up in treated cancer patients},
journal = {Cancer Medicine},
year = {2023},
volume = {12},
number = {15},
pages = {16531--16547},
doi = {10.1002/cam4.6243}
}
EUVIMED